S. Nakano

发表

MAP kinase phosphatase-1 is induced in abnormal fibers in inclusion body myositis

S. Nakano, A. Shinde, H. Ito, 2003, Neurology.

The spectrum of mutations causing end‐plate acetylcholinesterase deficiency

K. Ohno, M. Milone, A. Engel, 2000, Annals of neurology.

Cyclin-dependent Kinase 5 in Lewy Body-like Inclusions in Anterior Horn Cells of a Patient with Sporadic Amyotrophic Lateral Sclerosis

J. Kimura, S. Nakano, I. Akiguchi, 1997, Neurology.

Smad ubiquitination regulatory factor‐2 in progressive supranuclear palsy

S. Nakano, H. Ito, H. Kusaka, 2011, Neuropathology and applied neurobiology.

Accumulation of microtubule-based motor protein in a patient with colchicine myopathy

H. Shibasaki, S. Nakano, A. Shinde, 2000, Neurology.

A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome.

H. Fukuyama, Y. Nagahama, J. Kimura, 1995, Biochemical and biophysical research communications.

P39 immunoreactivity in glial cytoplasmic inclusions in brains with multiple system atrophy

S. Nakano, I. Akiguchi, Y. Kawamoto, 2001, Acta Neuropathologica.

Expression of an endoplasmic reticulum-resident chaperone, glucose-regulated stress protein 78, in the spinal cord of a mouse model of amyotrophic lateral sclerosis

S. Nakano, H. Kusaka, Hidefumi Ito, 2005, Acta Neuropathologica.

Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization.

S. Nakano, S. Nakamura, W. Araki, 1990, Journal of neural transmission. Supplementum.

Inclusion body myositis

J. Kimura, S. Nakano, A. Shinde, 2001, Neurology.

Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis

S. Nakano, H. Kusaka, Hidefumi Ito, 2006, Acta Neuropathologica.

p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson’s disease

J. Kimura, S. Nakano, I. Akiguchi, 1997, Acta Neuropathologica.

1,1' ‐Ethylidenebis‐ [tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia‐myalgia syndrome

A. Engel, A. N. Mayeno, S. Nakano, 1994, Neurology.

The role of p 62 / SQSTM 1 in sporadic inclusion body myositis

S. Nakano, H. Kusaka, M. Oki, 2017 .

The role of p62/SQSTM1 in sporadic inclusion body myositis

S. Nakano, H. Kusaka, M. Oki, 2017, Neuromuscular Disorders.

Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy.

S. Nakano, I. Akiguchi, S. Nakamura, 2000, Clinical neuropathology.

Cyclin-dependent Kinase 5 and Mitogen-activated Protein Kinase in Glial Cytoplasmic Inclusions in Multiple System Atrophy

J. Kimura, S. Nakano, I. Akiguchi, 1998, Journal of neuropathology and experimental neurology.

Immunohistochemical localization of phosphoinositide 3-kinase in brains with multiple system atrophy.

S. Nakano, I. Akiguchi, S. Nakamura, 2001, Clinical neuropathology.

Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis

S. Nakano, H. Kusaka, S. Ikehara, 2009, Brain Research.

Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant

R. Matsumoto, R. Takahashi, S. Nakano, 2014, Acta neuropathologica communications.

Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model

S. Nakano, H. Kusaka, Hidefumi Ito, 2008, Acta Neuropathologica.

The first Japanese patient with variant Creutzfeldt‐Jakob disease (vCJD)

S. Nakano, A. Shinde, H. Kusaka, 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan

I. Nishino, R. Kaji, S. Nakano, 2016, Orphanet Journal of Rare Diseases.

Activation of Transforming Growth Factor-β/Smad Signaling Reduces Aggregate Formation of Mislocalized TAR DNA-Binding Protein-43

J. Fujisawa, S. Nakano, H. Kusaka, 2012, Neurodegenerative Diseases.

Unequal crossing-over in unique PABP2 mutations in Japanese patients: a possible cause of oculopharyngeal muscular dystrophy.

Mika Nakamoto, S. Nakano, A. Shinde, 2002, Archives of neurology.

Messenger RNA degradation may be inhibited in sporadic inclusion body myositis

S. Nakano, A. Shinde, H. Ito, 2005, Neurology.

p 35 nck 5 a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson ’ s disease

J. Kimura, S. Nakano, I. Akiguchi, 2022 .

Localization of O-GlcNAc-modified proteins in neuromuscular diseases

S. Nakano, H. Kusaka, S. Kaneko, 2012, Medical Molecular Morphology.

Heterozygous UDP-GlcNAc 2-epimerase and N-acetylmannosamine kinase domain mutations in the GNE gene result in a less severe GNE myopathy phenotype compared to homozygous N-acetylmannosamine kinase domain mutations

M. Sonoo, Y. Hayashi, I. Nishino, 2012, Journal of the Neurological Sciences.

[A case of limbic encephalitis associated with Sjögren's syndrome mimicking anti N-methyl D-aspartate receptor encephalitis].

S. Nakano, R. Kanki, K. Yoshimura, 2018, Rinsho shinkeigaku = Clinical neurology.

Expression of caveolar components in primary desminopathy

S. Nakano, A. Shinde, H. Kusaka, 2008, Neuromuscular Disorders.

Evoked potential studies in mitochondrial encephalomyopathy.

S. Tsuji, A. Ohnishi, S. Nakano, 1990, Archives of neurology.

Nucleolar characteristics of reducing bodies in reducing body myopathy

H. Shibasaki, H. Sawada, S. Nakano, 2004, Acta Neuropathologica.

Myasthenia gravis

A. Engel, S. Nakano, 1993, Neurology.

In situ identification of hepatitis C virus RNA in muscle

S. Nakano, H. Ito, H. Kusaka, 2005, Neurology.

The Spectrum of Congenital End‐plate Acetylcholinesterase Deficiency a

P. Taylor, A. Engel, S. Nakano, 1993, Annals of the New York Academy of Sciences.

Myasthenic Syndromes Attributed to Mutations Affecting the Epsilon Subunit of the Acetylcholine Receptor a

R. Griggs, A. Engel, S. Nakano, 1993, Annals of the New York Academy of Sciences.

Myofibrillar Myopathy with Abnormal Foci of Desmin Positivity.: I. Light and Electron Microscopy Analysis of 10 Cases

A. Engel, S. Nakano, N. Busis, 1996, Journal of neuropathology and experimental neurology.

[Two sisters with dysferlinopathy manifesting different clinical phenotypes].

H. Shibasaki, Y. Hayashi, S. Nakano, 2003, Rinsho shinkeigaku = Clinical neurology.

[Patient of myofibrillar myopathy associated with muscle cramp and distal muscle involvement].

R. Matsumoto, R. Takahashi, S. Nakano, 2012, Rinsho shinkeigaku = Clinical neurology.

Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain

J. Kimura, S. Nakano, I. Akiguchi, 1996, Neuroscience.

Prednisolone-sparing effect of cyclosporin A therapy for very elderly patients with myasthenia gravis

S. Nakano, A. Shinde, H. Kusaka, 2013, Neuromuscular Disorders.

Congenital Myasthenic Syndrome Caused by Decreased Agonist Binding Affinity Due to a Mutation in the Acetylcholine Receptor ε Subunit

K. Ohno, S. Sine, M. Milone, 1996, Neuron.

New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome.

K. Ohno, S. Sine, C. Bouzat, 1996, Human molecular genetics.

The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan

I. Nishino, R. Kaji, H. Nodera, 2019, Orphanet Journal of Rare Diseases.

Myouclear Breakdown in Sporadic Inclusion Body Myositis

S. Nakano, H. Kusaka, 2011 .

Histone H1 is released from myonuclei and present in rimmed vacuoles with DNA in inclusion body myositis

Kengo Fujita, S. Nakano, A. Shinde, 2008, Neuromuscular Disorders.

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan

I. Higuchi, I. Nishino, S. Nakano, 2017, Journal of the Neurological Sciences.

[A case of hyperkalemic periodic paralysis presenting progressive myopathy with tubular aggregates].

S. Nakano, Junhui Yuan, K. Yoshimura, 2018, Rinsho shinkeigaku = Clinical neurology.

Congenital endplate acetylcholinesterase deficiency.

P. Taylor, A. Engel, S. Nakano, 1993, Brain : a journal of neurology.

Nuclear Contour Irregularity and Abnormal Transporter Protein Distribution in Anterior Horn Cells in Amyotrophic Lateral Sclerosis

S. Nakano, H. Kusaka, Hidefumi Ito, 2009, Journal of neuropathology and experimental neurology.

Localization of protein kinase C in human skeletal muscle

S. Shimohama, J. Kimura, S. Nakano, 1992, Muscle & nerve.

Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice

S. Nakano, H. Ito, H. Kusaka, 2008, Experimental Neurology.

Aberrant expression of cyclin-dependent kinase 5 in inclusion body myositis

J. Kimura, S. Nakano, I. Akiguchi, 1999, Neurology.

Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant

R. Matsumoto, R. Takahashi, S. Nakano, 2014, Acta neuropathologica communications.

Brain proton magnetic resonance spectroscopy and brain atrophy in myotonic dystrophy.

T. Inubushi, J. Kimura, J. Handa, 1999, Archives of neurology.

Immunohistochemical identification of messenger RNA-related proteins in basophilic inclusions of adult-onset atypical motor neuron disease

S. Nakano, H. Kusaka, Hidefumi Ito, 2008, Acta Neuropathologica.

[A case of cerebellar syndrome associated with HIV infection].

S. Nakano, A. Shinde, H. Kusaka, 2009, Rinsho shinkeigaku = Clinical neurology.

Immunohistochemical localization of CDK5 activator p39 in the rat brain.

S. Nakano, I. Akiguchi, S. Nakamura, 1999, NeuroReport.

Myonuclear breakdown in sporadic inclusion body myositis is accompanied by DNA double strand breaks

S. Nakano, A. Shinde, H. Kusaka, 2011, Neuromuscular Disorders.

[A patient of MELAS with 3271 mutation with fatal outcome after alcohol intake].

S. Nakano, A. Shinde, I. Akiguchi, 2000, Rinsho shinkeigaku = Clinical neurology.

Inclusion body myositis: Expression of extracellular signal-regulated kinase and its substrate

J. Kimura, S. Nakano, A. Shinde, 2001 .

Acetylcholinesterase histochemistry in the non‐endplate region of skeletal muscles and effect of denervation

S. Nakano, Shigenobu Nakamura, I. Akiguchi, 1990, Muscle & nerve.

[Patient with chronic sarcoid myopathy without other organ involvement].

S. Nakano, K. Tatsuno, Seika Nakamura, 2014, Rinsho shinkeigaku = Clinical neurology.

Our Experience of Muscle Afferent Block for dystonia and spasticity

S. Nakano, H. Kusaka, Hisashi Ito, 2002 .

[A case of rigid spine syndrome with congenital cardiac abnormality of sinus venosus defect].

S. Nakano, I. Akiguchi, M. Nakamura, 1995, Rinsho shinkeigaku = Clinical neurology.